These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity. Carroll B; Maetzel D; Maddocks OD; Otten G; Ratcliff M; Smith GR; Dunlop EA; Passos JF; Davies OR; Jaenisch R; Tee AR; Sarkar S; Korolchuk VI Elife; 2016 Jan; 5():. PubMed ID: 26742086 [TBL] [Abstract][Full Text] [Related]
4. PDK4 protein promotes tumorigenesis through activation of cAMP-response element-binding protein (CREB)-Ras homolog enriched in brain (RHEB)-mTORC1 signaling cascade. Liu Z; Chen X; Wang Y; Peng H; Wang Y; Jing Y; Zhang H J Biol Chem; 2014 Oct; 289(43):29739-49. PubMed ID: 25164809 [TBL] [Abstract][Full Text] [Related]
5. RhoA modulates signaling through the mechanistic target of rapamycin complex 1 (mTORC1) in mammalian cells. Gordon BS; Kazi AA; Coleman CS; Dennis MD; Chau V; Jefferson LS; Kimball SR Cell Signal; 2014 Mar; 26(3):461-7. PubMed ID: 24316235 [TBL] [Abstract][Full Text] [Related]
6. MCRS1 binds and couples Rheb to amino acid-dependent mTORC1 activation. Fawal MA; Brandt M; Djouder N Dev Cell; 2015 Apr; 33(1):67-81. PubMed ID: 25816988 [TBL] [Abstract][Full Text] [Related]
7. Re-evaluating the roles of proposed modulators of mammalian target of rapamycin complex 1 (mTORC1) signaling. Wang X; Fonseca BD; Tang H; Liu R; Elia A; Clemens MJ; Bommer UA; Proud CG J Biol Chem; 2008 Nov; 283(45):30482-92. PubMed ID: 18676370 [TBL] [Abstract][Full Text] [Related]
8. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease. Zhang H; Li Q; Graham RK; Slow E; Hayden MR; Bezprozvanny I Neurobiol Dis; 2008 Jul; 31(1):80-8. PubMed ID: 18502655 [TBL] [Abstract][Full Text] [Related]
9. Redox regulates mammalian target of rapamycin complex 1 (mTORC1) activity by modulating the TSC1/TSC2-Rheb GTPase pathway. Yoshida S; Hong S; Suzuki T; Nada S; Mannan AM; Wang J; Okada M; Guan KL; Inoki K J Biol Chem; 2011 Sep; 286(37):32651-60. PubMed ID: 21784859 [TBL] [Abstract][Full Text] [Related]
10. cAMP inhibits mammalian target of rapamycin complex-1 and -2 (mTORC1 and 2) by promoting complex dissociation and inhibiting mTOR kinase activity. Xie J; Ponuwei GA; Moore CE; Willars GB; Tee AR; Herbert TP Cell Signal; 2011 Dec; 23(12):1927-35. PubMed ID: 21763421 [TBL] [Abstract][Full Text] [Related]
11. Rheb/mTORC1 signaling promotes kidney fibroblast activation and fibrosis. Jiang L; Xu L; Mao J; Li J; Fang L; Zhou Y; Liu W; He W; Zhao AZ; Yang J; Dai C J Am Soc Nephrol; 2013 Jun; 24(7):1114-26. PubMed ID: 23661807 [TBL] [Abstract][Full Text] [Related]
12. Activation of Rheb, but not of mTORC1, impairs spine synapse morphogenesis in tuberous sclerosis complex. Yasuda S; Sugiura H; Katsurabayashi S; Shimada T; Tanaka H; Takasaki K; Iwasaki K; Kobayashi T; Hino O; Yamagata K Sci Rep; 2014 Jun; 4():5155. PubMed ID: 24889507 [TBL] [Abstract][Full Text] [Related]
13. Striatal expression of a calmodulin fragment improved motor function, weight loss, and neuropathology in the R6/2 mouse model of Huntington's disease. Dai Y; Dudek NL; Li Q; Fowler SC; Muma NA J Neurosci; 2009 Sep; 29(37):11550-9. PubMed ID: 19759302 [TBL] [Abstract][Full Text] [Related]
14. Glycolytic flux signals to mTOR through glyceraldehyde-3-phosphate dehydrogenase-mediated regulation of Rheb. Lee MN; Ha SH; Kim J; Koh A; Lee CS; Kim JH; Jeon H; Kim DH; Suh PG; Ryu SH Mol Cell Biol; 2009 Jul; 29(14):3991-4001. PubMed ID: 19451232 [TBL] [Abstract][Full Text] [Related]
15. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD). Ratovitski T; Arbez N; Stewart JC; Chighladze E; Ross CA Cell Cycle; 2015; 14(11):1716-29. PubMed ID: 25927346 [TBL] [Abstract][Full Text] [Related]
17. Caspase-6 activity in a BACHD mouse modulates steady-state levels of mutant huntingtin protein but is not necessary for production of a 586 amino acid proteolytic fragment. Gafni J; Papanikolaou T; Degiacomo F; Holcomb J; Chen S; Menalled L; Kudwa A; Fitzpatrick J; Miller S; Ramboz S; Tuunanen PI; Lehtimäki KK; Yang XW; Park L; Kwak S; Howland D; Park H; Ellerby LM J Neurosci; 2012 May; 32(22):7454-65. PubMed ID: 22649225 [TBL] [Abstract][Full Text] [Related]
18. Amino acid regulation of TOR complex 1. Avruch J; Long X; Ortiz-Vega S; Rapley J; Papageorgiou A; Dai N Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E592-602. PubMed ID: 18765678 [TBL] [Abstract][Full Text] [Related]
19. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease. Hermel E; Gafni J; Propp SS; Leavitt BR; Wellington CL; Young JE; Hackam AS; Logvinova AV; Peel AL; Chen SF; Hook V; Singaraja R; Krajewski S; Goldsmith PC; Ellerby HM; Hayden MR; Bredesen DE; Ellerby LM Cell Death Differ; 2004 Apr; 11(4):424-38. PubMed ID: 14713958 [TBL] [Abstract][Full Text] [Related]